ANTIDEPRESSANT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Antidepressant Market, By Drug Class (Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine, Sertraline, and Others), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (Venlafaxine, Duloxetine, and Others), Tricyclic Antidepressants (TCAs), Monoamine Oxidase Inhibitors (MAOIs), and Atypical Antidepressants), By Route of Administration (Oral, Subcutaneous, Intravenous, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 02 Apr, 2026
Code: CMI7243
Page number: 167
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Antidepressant Market, By Drug Class, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Selective Serotonin Reuptake Inhibitors (SSRIs)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Fluoxetine
    - Sertraline
    - Others
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Venlafaxine
    - Duloxetine
    - Others
- Tricyclic Antidepressants (TCAs)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Amitriptyline
    - Imipramine
    - Others
- Monoamine Oxidase Inhibitors (MAOIs)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Phenelzine
    - Tranylcypromine
    - Others
- Atypical Antidepressants
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Bupropion
    - Trazodone
    - Others
Global Antidepressant Market, By Route of Administration, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Subcutaneous
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Intravenous
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Antidepressant Market, By Distribution Channel, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospitals Pharmacy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Retail Pharmacy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Online Pharmacy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Antidepressant Market, By Region, 2021 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Eli Lilly and Company
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GlaxoSmithKline PLC
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AstraZeneca
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AbbVie Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - H. Lundbeck AS
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bristol-Myers Squibb
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Alkermes Plc
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - F. Hoffmann-La Roche Ltd
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Neurocrine Biosciences, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Otsuka Pharmaceutical Co., Ltd.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Indivior PLC
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Aurobindo Pharma
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Antidepressant Market” -Global forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now